Journal
Nature Medicine
ISSN 1078-8956 · Nature Portfolio
Published here
14 counted works of 15 linked
| Year | Title | Academics | Sources |
|---|---|---|---|
| 2026 | Reproducibility in Biomedical Research in progress | Peter K. Enns | CV |
| 2025 | In Vivo Base Editing Extends Lifespan of a Humanized Mouse Model of Prion Disease | David R. Liu | CV |
| 2024 | A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features | Xiaowei Zhuang | CV OA GS |
| 2023 | A simulation-based comparative effectiveness analysis of policies to improve global maternal health outcomes | Gary King | CV OA GS |
| 2023 | Efficient In Vivo Genome Editing Prevents Hypertrophic Cardiomyopathy in Mice | David R. Liu | CV |
| 2023 | Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease. | Emily Balskus | CV OA |
| 2023 | Simulation-based estimates and projections of global, regional and country-level maternal mortality by cause, 1990–2050 | Gary King | CV OA GS |
| 2021 | No Causal Effect of School Closures in Japan on the Spread of COVID-19 in Spring 2020 | Charles T. Mcclean | CV OA GS |
| 2021 | Public opinion on global rollout of COVID-19 vaccines. | Peter John Loewen | CV OA GS |
| 2021 | Vaccine Acceptance and Hesitancy in Low and Middle Income Countries, and Implications for Messaging | Sarah E. Kreps | CV OA GS |
| 2020 | Building an International Consortium for Tracking Coronavirus Health Status | Gary King | CV OA GS |
| 2020 | Building an international consortium for tracking coronavirus health status (vol 78, pg 931, 2020) | Gary King | GS |
| 2019 | Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma | David R. Liu | GS |
| 2017 | Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors | Joshua Rabinowitz | GS |
| 2016 | A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance | Joshua Rabinowitz | GS |